News and Trends 5 Nov 2018
Series C Bags German Company €17M for Irregular Heartbeat Treatment
Omeicos Therapeutics has secured €17M in a Series C round to fund clinical development of its lead treatment for irregular…
Cardiovascular disease
- Latest Posts
In Depth 30 Oct 2018
Shuttles, Bubbles and Ultrasound: Crossing the Blood–Brain Barrier
What do shuttles, bubbles and ultrasound have in common? They are all methods that can all be used to target…
News and Trends 26 Sep 2018
Fish Oils Finally Reel in Positive Results for Cardiovascular Disease
Purified fish oil can reduce patients’ risks for adverse cardiovascular events by 25%, according to US-Irish Biotech Amarin’s Phase III…
More News! 25 Sep 2018
24-Hour Blood Pressure Bracelet Could Combat Hypertension
For those with blood pressure problems who hate blood pressure cuffs, hope is here. Swiss biotech aktiia has raised €3.6M…
ADVERTISEMENT
News and Trends 4 Jul 2018
Stem Cells Could Help Patients Recover From Heart Attacks
Viscofan BioEngineering has a green light in Spain to start clinical testing for its stem cell technology in patients with…
More News! 18 Jun 2018
Swiss Biotech Tackles Brain Artery Constriction Caused by Hemorrhage
Idorsia will start a Phase III trial to study the efficacy of its drug in treating the constriction of arteries…
News and Trends 3 May 2018
World’s First Gene Therapy Developer Raises $128M for Hemophilia and Huntington’s
uniQure has raised a substantial public offering on the NASDAQ. The funding could help the Dutch biotech advance two new gene…
News and Trends 14 Mar 2018
A New Drug for Atrial Fibrillation Starts Human Testing in Europe
Update (14/03/2018): Acesion Pharma has started a Phase I clinical trial at the Centre for Human Drug Research (CHDR) in…
More News! 1 Mar 2018
Just a Single Dose of this Drug Boosts the Survival of Heart Failure Patients
Berlin Cures' drug fights off self-reactive antibodies that are associated with 80% of heart failure cases to improve heart function…
News and Trends 21 Feb 2018
Implantation of Carmat’s Artificial Heart Begins in Denmark to Beat Low Enrolment
Carmat's artificial heart is being tested in patients with heart failure. A hospital in Copenhagen will implant the device, which the…
Startup Scout 26 Jan 2018
This Danish Biotech is Working on Better, Safer Drugs for Cardiac Arrhythmia
This week, we're visiting Acesion Pharma in Copenhagen, a biotech that is developing more effective, safer drugs for atrial fibrillation, the…
News and Trends 25 Jan 2018
British Biotech Treats First Phase III Patient in its Critical Limb Ischemia Trial
Rexgenero has treated the first patient in a Phase III trial investigating REX-001, the biotech's cell therapy for critical limb ischemia.…
More News! 18 Jan 2018
First Patient Successfully Implanted with Heart Valve Replacement Device
French company Kephalios has successfully implanted a new adjustable device to repair a heart valve defect in a human patient for the…
News and Trends 15 Jan 2018
This is Why You Should Avoid Eating too Much Junk Food
Following last week's article about the importance of eating plenty of fruit and vegetables, German researchers have unearthed another link…
Best in Biotech 18 Dec 2017
Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017
Now that we've got the bad news out of the way, we're here to spread some Christmas cheer with the…
Best in Biotech 12 Dec 2017
Grab the Tissues: Here are the 8 Biggest European Biotech Clinical Failures of 2017
As 2016 was a tough year for biotech, 2017 was under pressure to turn things around. Although there has been…
ADVERTISEMENT
News and Trends 4 Dec 2017
Swiss Biotech Brings in Reinforcements to See Hypertension Drug Through Phase III
Idorsia will collaborate with Janssen on the development of its hypertension drug, aprocitentan, which could help to prevent future heart…
News and Trends 15 Nov 2017
Swiss Biotech Rakes in Biggest Fundraising of 2017 to Regenerate Heart Valves
Xeltis has raised a €45M Series C to boost the development of its pioneering medical device, RestoreX, which helps to…
News and Trends 13 Nov 2017
Spanish Biotech Gets €2.4M to Spot Myocardial Infarction Before it’s Too Late
GlyCardial Diagnostics believes it has the technology to prevent premature myocardial infarctions, 80% of which are preventable. Barcelona-based GlyCardial Diagnostics is…
News and Trends 2 Nov 2017
AstraZeneca and Moderna want to beat Novartis at Treating Heart Failure
AstraZeneca will work with Moderna Therapeutics to bring together to the market an mRNA version of Novartis' failed heart failure drug Serelaxin. AstraZeneca has…
